Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Reata Pharmaceuticals Stock Quote

Reata Pharmaceuticals (NASDAQ: RETA)

Some price data may be temporarily unavailable.

Reata Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
RETA +679.20% +104.82% +15.42% +1,219%
S&P +22.34% +74.52% +11.78% +142%

Reata Pharmaceuticals Company Info

In an industry in which many biotech companies focus only on diseases that affect huge numbers of people, Reata provides some diversification with its focus on orphan conditions.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.